COVID-19 Spike RBD and Membrane Protein Human IgG ELISA Assay |
MBS412772-48AntigenWells48ControlAntigenWells |
MyBiosource |
48AntigenWells&48ControlAntigenWells |
EUR 635 |
Human IgG antibody Laboratories manufactures the idt protein spike reagents distributed by Genprice. The Idt Protein Spike reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Idt products are available in stock. Specificity: Idt Category: Protein Group: Spike
Spike information
SARS-CoV Spike Protein |
abx060655-50g |
Abbexa |
50 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060656-100g |
Abbexa |
100 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060656-10g |
Abbexa |
10 µg |
EUR 1962.5 |
SARS-CoV Spike Protein |
abx060656-50g |
Abbexa |
50 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060657-100g |
Abbexa |
100 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060657-10g |
Abbexa |
10 µg |
EUR 1962.5 |
SARS-CoV Spike Protein |
abx060657-50g |
Abbexa |
50 µg |
Ask for price |
Spike hFc fusion protein |
NCP0115 |
Bioworld Biotech |
100ug |
EUR 398 |
|
Description: The cause of the COVID-19 pandemic is a novel and highly pathogenic coronavirus, termed SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2). SARS-CoV-2 is a member of the Coronaviridae family of viruses (1). The genome of SARS-CoV-2 is similar to other coronaviruses, and is comprised of four key structural proteins: S, the spike protein, E, the envelope protein, M, the membrane protein, and N, the nucleocapsid protein (2). Coronavirus spike proteins are class I fusion proteins and harbor an ectodomain, a transmembrane domain, and an intracellular tail. The highly glycosylated ectodomain projects from the viral envelope surface and facilitates attachment and fusion with the host cell plasma membrane. The ectodomain can be further subdivided into host receptor-binding domain (RBD) (S1) and membrane-fusion (S2) subunits, which are produced upon proteolysis by host proteases at S1/S2 and S2’ sites. S1 and S2 subunits remain associated after cleavage and assemble into crown-like homotrimers. In humans, both SARS-CoV and SARS-CoV-2 spike proteins utilize the angiotensin-converting enzyme 2 (ACE2) protein as a receptor for cellular entry. Spike protein subunits represent a key antigenic feature of coronavirus virions, and therefore represent an important target of vaccines, novel therapeutic antibodies, and small-molecule inhibitors. |
Spike S protein library |
SB043 |
Smartox Biotechnology |
0.5 |
EUR 2326.75 |
Description: Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane. The S1 subunit allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.Spike (S) is a glycoprotein of 1 273 aa length. sb-PEPTIDE offers a library made of 316 peptides with a length of 15 amino acids and an overlap of 11 amino acids without post-translational modificaton. |
Anti-SARS Spike Protein |
18950 |
Genovis AB |
100ul |
EUR 551 |
Anti-SARS Spike Protein |
18951 |
Genovis AB |
100ul |
EUR 551 |
Anti-SARS Spike Protein |
18954 |
Genovis AB |
100ul |
EUR 551 |
Recombinant Spike Protein (SP) |
MBS2124707-001mg |
MyBiosource |
0.01mg |
EUR 155 |
Recombinant Spike Protein (SP) |
MBS2124707-005mg |
MyBiosource |
0.05mg |
EUR 260 |
Recombinant Spike Protein (SP) |
MBS2124707-01mg |
MyBiosource |
0.1mg |
EUR 375 |
Recombinant Spike Protein (SP) |
MBS2124707-02mg |
MyBiosource |
0.2mg |
EUR 460 |
Recombinant Spike Protein (SP) |
MBS2124707-05mg |
MyBiosource |
0.5mg |
EUR 860 |